WILLIAM HEATLEY

I continue to create and develop a confidential campaign for a new GlaxoSmithKline pharmaceutical that is now in Phase 3 trials.

• Initiating brainstorming sessions on how the product will roll out throughout all media.

• Developed and deployed interactive projects for oncology patients undergoing KEYTRUDA treatment.
• Revised educational resources for healthcare professionals managing cervical, endometrial, and breast cancer cases.
• Collaborated with clinical teams to enhance patient support tools for immunotherapy.
• Designed user-friendly materials to clarify the indications for KEYTRUDA in cancer care.

Revamped a WL Gore website, focusing on aortic stents and other affordable medical devices for developing countries. Modified content to meet the needs of physicians, patients, and families. Improved site effectiveness by restructuring content and enhancing reader comprehension

• Created non-branded digital campaign for TEVA pharmaceuticals: This new site takes a fresh empowering look at birth control without the baggage of religion and politics.

• Big digital re-boot of orphan drug, INCRELEX Website for IPSEN biopharmaceuticals. Site is now much more user-friendly for parents and caregivers and anyone who peeks.

• Managed care market, Direct to physician, Direct to patient: Branded and non-branded issue briefs. Digital, direct mail and email to patient. Novartis/GLEEVEC.